| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 04/15/2004 | US20040072172 Comprises enzymatic polypeptide associated with calcium dependent movement of phospholipids through plasmid membranes for diagnosis and treatment of thrombosis, angina pectoris and stroke; gene therapy |
| 04/15/2004 | US20040072168 Novel deoxynucleoside kinase enzyme variants |
| 04/15/2004 | US20040072165 Method for producing dna encoding polypeptides that are composed of several section, and for producing polypeptides by expressing the dna thus obtained |
| 04/15/2004 | US20040072159 Bzip type transcription factors regulating the expression of rice storage protein |
| 04/15/2004 | US20040072154 Novel compositions and methods for cancer |
| 04/15/2004 | US20040071853 For improving rheological properties of a flour dough and the quality of bread, alimentary paste products, noodles and cakes |
| 04/15/2004 | US20040071737 Polysaccharides and/or glycopeptides preparable from keratinophilic fungi and yeasts; vaccines, immunomodulators, and antiallergens; precipitation and separation of supernatant; treatment with mineral or organic acid |
| 04/15/2004 | US20040071731 Chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 04/15/2004 | US20040071730 Polypeptides and polynucleotides; genetic engineering; medical diagnosis |
| 04/15/2004 | US20040071729 Comprising amino acid sequences of streptococcal matrix adhesion (Ema) polypeptides |
| 04/15/2004 | US20040071725 Administered with target antigens to treat infections; anticarcinogenic and antitumor agents; genetic engineering |
| 04/15/2004 | US20040071724 Heat shock protein-based vaccines and immunotherapies |
| 04/15/2004 | US20040071721 A fusion protein of antigen and heat shock protein; DNA therapy promoting gene expression in mammal cells, treating infectious diseases and cancers, tumors; polynucleotide construct vectors |
| 04/15/2004 | US20040071720 A fusion protein of antigen and heat shock protein; DNA therapy promoting gene expression in mammal cells, treating infectious diseases and cancers, tumors; polynucleotide construct vectors |
| 04/15/2004 | US20040071717 Recombinant DNA encoding the major allergen of plantago lanceolata pollen, Pla I 1, and applications thereof |
| 04/15/2004 | US20040071714 A gene expressed polypeptide is used in food, for treating food allergy |
| 04/15/2004 | US20040071713 A protein is obtained from gene expression of Pseudomonas aeruginosa, molecular weight range from 13 kDa to 80 kDa, purification, antibody, immunization with vaccine antigens, treating bacterial infections |
| 04/15/2004 | US20040071712 Modified peptides as therapeutic agents |
| 04/15/2004 | US20040071711 Imaging, diagnosis and treatment of disease |
| 04/15/2004 | US20040071699 An antagonists, or agonists, producing antibodies, used as immunotherapy treating allergy, acquired immune deficiency syndrome, autoimmune diabetes, thyroiditis |
| 04/15/2004 | US20040071695 Novel g-protein coupled receptor |
| 04/15/2004 | US20040071680 Lactobacillus reuteri PRD202(KCTC-10301BP) which converts monosaccharides and disaccharides into intestinal nonabsorb-able polysaccharides |
| 04/15/2004 | US20040071676 Yeast expression vector and a method of making a recombinant protein by expression in a yeast cell |
| 04/15/2004 | US20040071669 Transplants for myocardial scars |
| 04/15/2004 | US20040071655 Binding agent |
| 04/15/2004 | US20040071636 Bacteriophage-encoded enzymes for the treatment and prevention of dental caries and periodontal diseases |
| 04/15/2004 | CA2503163A1 Detection of biological threat agents |
| 04/15/2004 | CA2501958A1 Polynucleotides and polypeptides derived from lactobacillus rhamnosus hn001 |
| 04/15/2004 | CA2501264A1 Method of producing polyunsaturated fatty acids with yeasts through the incorporation of olefinic or acetylenic substrates |
| 04/15/2004 | CA2501068A1 Human artificial chromosome (hac) vector |
| 04/15/2004 | CA2501000A1 High sensitivity quantitation of peptides by mass spectrometry |
| 04/15/2004 | CA2500883A1 Mouse-origin proteins forming domain or use thereof |
| 04/14/2004 | EP1408123A1 A microorganism in which the fadR gene is knocked out and a process for producing L-threonine using the microorganism |
| 04/14/2004 | EP1408119A1 Method of screening abc protein promoter/inhibitor |
| 04/14/2004 | EP1408108A2 Cellulase producing actinomycetes, cellulase produced therefrom and method of producing same |
| 04/14/2004 | EP1408050A1 A method of producing glucagon-like peptide 1(glp-1)7-36 and an glp-1 analogue |
| 04/14/2004 | EP1407678A1 Capsules containing vital cells or tissues |
| 04/14/2004 | EP1407054A2 Expression system |
| 04/14/2004 | EP1407051A2 Universal method and composition for the rapid lysis of cells for the release of nucleic acids and their detection |
| 04/14/2004 | EP1407044A2 Rna interference mediating small rna molecules |
| 04/14/2004 | EP1407041A1 Method for obtaining a titrated preparation of algae and resulting titrated preparations |
| 04/14/2004 | EP1407038A2 A thermostable isomerase and use thereof, in particular for producing tagatose |
| 04/14/2004 | EP1407035A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an attenuated aspa gene |
| 04/14/2004 | EP1407034A2 Recombination systems and a method for removing nucleic acid sequences from the genome of eukaryotic organisms |
| 04/14/2004 | EP1407033A1 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 04/14/2004 | EP1407031A1 Transformation of eukaryotic cells by mobilizable plasmids |
| 04/14/2004 | EP1407030A2 Methods for large scale production of recombinant dna-derived tpa or k2s molecules |
| 04/14/2004 | EP1407028A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced suca or sucb gene |
| 04/14/2004 | EP1407027A2 Process for the preparation of l-amino acids using strains of the entenobacteriaceae familiy which contain an enhanced succ or sucd gene |
| 04/14/2004 | EP1407026A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced phob or phor gene |
| 04/14/2004 | EP1407025A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced male gene |
| 04/14/2004 | EP1407024A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced phoe gene |
| 04/14/2004 | EP1407023A2 Group b streptococcus antigens and corresponding dna fragments |
| 04/14/2004 | EP1407022A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced rsea or rsec gene |
| 04/14/2004 | EP1407021A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an attenuated ugpb gene |
| 04/14/2004 | EP1407020A2 Stress-associated genetic products from ashbya gossypii |
| 04/14/2004 | EP1407019A2 Intestinal proteins |
| 04/14/2004 | EP1407017A2 Human tumor necrosis factor receptor |
| 04/14/2004 | EP1407016A2 Compositions and methods relating to breast specific genes and proteins |
| 04/14/2004 | EP1407015A2 Compositions and methods relating to breast specific genes and proteins |
| 04/14/2004 | EP1407014A2 Screening method for attenuating or virulence defective microbial cells |
| 04/14/2004 | EP1407013A1 Mutations in ion channels |
| 04/14/2004 | EP1407010A1 Regulation of human aminopeptidase n |
| 04/14/2004 | EP1407001A1 Disposable vessel |
| 04/14/2004 | EP1406999A1 Recovery of bioleaching microbes |
| 04/14/2004 | EP1406931A2 Modification of human variable domains |
| 04/14/2004 | EP1406929A2 Glycoprotein vi fusion proteins |
| 04/14/2004 | EP1406928A1 Ntb-a, a surface molecule involved in natural killer cells activity |
| 04/14/2004 | EP1406925A2 Survivin interacting protein tpr1 |
| 04/14/2004 | EP1406923A2 Histidine phosphatase interacting protein with 180kd |
| 04/14/2004 | EP1406653A2 T cell regulatory genes and methods of use thereof |
| 04/14/2004 | EP1406645A2 Novel human transporter proteins and polynucleotides encoding the same |
| 04/14/2004 | EP1406489A2 Eukaryotic genes involved in adult lifespan regulation |
| 04/14/2004 | EP1242578B1 Cell culture medim containing growth factors and l-glutamine |
| 04/14/2004 | EP0876493B1 Production of bacillus thuringiensis integrants |
| 04/14/2004 | EP0809434B1 Control of post-harvest fungal disease using saprophytic yeast |
| 04/14/2004 | EP0707487B1 Methods and pharmaceutical compositions useful for treating neurological disorders |
| 04/14/2004 | EP0531372B2 A cellulase preparation comprising an endoglucanase enzyme |
| 04/14/2004 | CN1489692A HCV antigen/antibody combination assay |
| 04/14/2004 | CN1489629A MIcrobiological method for producing L-carnitine |
| 04/14/2004 | CN1489628A Compounds and methods for treatment and diagnosis of chlamydial infection |
| 04/14/2004 | CN1489627A Method and compositions for synthesis of nuclear acid molecules using multiple recognition sites |
| 04/14/2004 | CN1489476A Method of preparing biological materials and preparation produced using same |
| 04/14/2004 | CN1489473A Silensed anti-CD 28 antibodies and use thereof |
| 04/14/2004 | CN1489472A Improved mycoplasma hyopneumoniae bacterin vaccine |
| 04/14/2004 | CN1488751A Fungus bacterial culture medium |
| 04/14/2004 | CN1145798C In vitro method for determining presence of hepatocellular carcindoma |
| 04/14/2004 | CN1145703C Process for fermentative production of deacylated cephaloporins |
| 04/14/2004 | CN1145702C Sturctural member having expression element and use in regulating nucleotide sequential expression |
| 04/14/2004 | CN1145699C Phenylacetyl-CoA ligase from penicillium chrysogenum |
| 04/14/2004 | CN1145698C Synthetic insecticide crystalline protein gene |
| 04/14/2004 | CN1145697C 治疗和诊断组合物 Therapeutic and diagnostic compositions |
| 04/14/2004 | CN1145696C Antifungal proteins |
| 04/14/2004 | CN1145693C Amino-terminally truncated MCP-2 as chemokine antagnosits |
| 04/14/2004 | CN1145692C Hypersensitive response induced resistance in plants by seed treatment |
| 04/13/2004 | US6720476 CTR1 homologue from melon |
| 04/13/2004 | US6720415 S-ribosylhomocysteine to homocysteine; bacterial genes involved in biosynthesis of the signaling molecule; bacterial autoinducer-2 signaling molecule; luminescence in the vibrio harveyi signaling system 2 bioassay; luxq luminescence genes |
| 04/13/2004 | US6720410 Nucleic acids encoding enamel matrix related polypeptides |
| 04/13/2004 | US6720310 Transfer method for specific cellular localization of nucleic acids |
| 04/13/2004 | US6720183 Cytoplasmic inhibition of gene expression |